BioXcel Therapeutics, Inc. Gains 55.01%
Fri 14 Feb 20 at 05:30 PM
BioXcel Therapeutics, Inc. (BTAI:NASDAQ) jumped higher at $36.97, a gain of 55%. On Thu 13 Feb 20, BTAI:NASDAQ touched a New 2-Week High of $23.85. The stock got featured on our News Catalysts scanner on Fri 07 Feb 20 at 08:23 AM in the 'MISCELLANEOUS' category. From Fri 24 Jan 20, the stock recorded 57.14% Up Days and 60.00% Green Days
About BioXcel Therapeutics, Inc. (BTAI:NASDAQ)
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Top 10 Gainers:
- Summer Infant, Inc. (SUMR:NASDAQ), 288.03%
- Genprex, Inc. (GNPX:NASDAQ), 56.2%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 55.01%
- Zosano Pharma Corporation (ZSAN:NASDAQ), 38.55%
- Digital Ally, Inc. (DGLY:NASDAQ), 34.89%
- PAVmed Inc. (PAVM:NASDAQ), 32.26%
- ImmunoGen, Inc. (IMGN:NASDAQ), 26.87%
- Huitao Technology Co., Ltd. (HHT:NASDAQ), 24.18%
- The Chemours Company (CC:NYSE), 23.53%
- scPharmaceuticals Inc. (SCPH:NASDAQ), 21.86%